Download PDF
Clin Colon Rectal Surg 2018; 31(06): 368-378
DOI: 10.1055/s-0038-1668107
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Basic Science, Epidemiology, and Screening for Anal Intraepithelial Neoplasia and Its Relationship to Anal Squamous Cell Cancer

Kurt G. Davis
1   Section of Colon and Rectal Surgery, LSU Department of Surgery, LSU School of Medicine, New Orleans, Louisiana
,
Guy R. Orangio
1   Section of Colon and Rectal Surgery, LSU Department of Surgery, LSU School of Medicine, New Orleans, Louisiana
› Author Affiliations
Further Information

Publication History

Publication Date:
02 November 2018 (online)

    Permissions and Reprints

Abstract

Despite the progress made in the reduction of squamous cell carcinoma of the cervix, the incidence of anal squamous cell carcinoma (ASCC) has been increasing since 1992. While it remains an uncommon disease, the prevalence is climbing steadily. Among human immunodeficiency virus (HIV)-infected adults, especially men who have sex with men, ASCC is one of the more common non-AIDS-defining malignancies. The precursor lesion, anal intraepithelial neoplasia (AIN), is prevalent in the HIV-infected population. More than 90% of ASCCs are related to human papilloma virus (HPV), oncogenic types (HPV 16, 18). While the biology of HPV-related intraepithelial neoplasia is consistent in the anogenital area, the natural history of AIN is poorly understood and is not identical to cervical intraepithelial neoplasia (CIN). CIN is also considered an AIDS-defining malignancy, and the methods for screening and prevention of AIN are derived from the CIN literature. This article will discuss the epidemiology of ASCC and its association with HPV and the life cycle of the HPV, and the molecular changes that lead to clearance, productive infection, latency, and persistence. The immunology of HPV infection will discuss natural immunity, humoral and cellular immunity, and how the HPV virus evades and interferes with these mechanisms. We will also discuss high-risk factors for developing AIN in high-risk patient populations with relation to infections (HIV, HPV, and chlamydia infections), prolonged immunocompromised people, and sexual behavior and tobacco abuse. We will also discuss the pre- and post-HAART era and its effect on AINs and ASCC. Finally, we will discuss the importance of anal cytology and high-resolution anoscopy with and without biopsy in this high-risk population.

Keywords

non–AIDS-defining malignancy - anal intraepithelial neoplasia - human papilloma virus - anal cytology - high-resolution anoscopy
 

  • References

  • 1 Piketty C, Selinger-Leneman H, Bouvier AM. , et al. Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the French hospital database on HIV. J Clin Oncol 2012; 30 (35) 4360-4366
    CrossrefPubMedGoogle Scholar
  • 2 The Surveillance, Epidemiology, and End Results (SEER) Program. Available at: http://seer.cancer.gov/ . Accessed February 9, 2018
    PubMed
  • 3 Nelson RA, Levine AM, Bernstein L, Smith DD, Lai LL. Changing patterns of anal canal carcinoma in the United States. J Clin Oncol 2013; 31 (12) 1569-1575
    CrossrefPubMedGoogle Scholar
  • 4 Frisch M. On the etiology of anal squamous carcinoma. Dan Med Bull 2002; 49 (03) 194-209
    PubMedGoogle Scholar
  • 5 Chiao EY, Krown SE, Stier EA, Schrag D. A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. J Acquir Immune Defic Syndr 2005; 40 (04) 451-455
    CrossrefPubMedGoogle Scholar
  • 6 Piketty C, Selinger-Leneman H, Grabar S. , et al; FHDH-ANRS CO 4. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS 2008; 22 (10) 1203-1211
    CrossrefPubMedGoogle Scholar
  • 7 Piketty C, Selinger-Leneman H, Bouvier AM. , et al. Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the French hospital database on HIV. J Clin Oncol 2012; 30 (35) 4360-4366
    CrossrefPubMedGoogle Scholar
  • 8 de Pokomandy A, Rouleau D, Ghattas G. , et al. HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV. Clin Infect Dis 2011; 52 (09) 1174-1181
    CrossrefPubMedGoogle Scholar
  • 9 Shiels MS, Kreimer AR, Coghill AE, Darragh TM, Devesa SS. Anal cancer incidence in the United States, 1977-2011: distinct patterns by histology and behavior. Cancer Epidemiol Biomarkers Prev 2015; 24 (10) 1548-1556
    CrossrefPubMedGoogle Scholar
  • 10 Daling JR, Madeleine MM, Johnson LG. , et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101 (02) 270-280
    CrossrefPubMedGoogle Scholar
  • 11 Gami B, Kubba F, Ziprin P. Human papilloma virus and squamous cell carcinoma of the anus. Clin Med Insights Oncol 2014; 8: 113-119
    PubMedGoogle Scholar
  • 12 Grulich AE, Poynten IM, Machalek DA, Jin F, Templeton DJ, Hillman RJ. The epidemiology of anal cancer. Sex Health 2012; 9 (06) 504-508
    CrossrefPubMedGoogle Scholar
  • 13 Silverberg MJ, Lau B, Justice AC. , et al; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis 2012; 54 (07) 1026-1034
    CrossrefPubMedGoogle Scholar
  • 14 de Pokomandy A, Rouleau D, Ghattas G. , et al; HIPVIRG Study Group. Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. J Infect Dis 2009; 199 (07) 965-973
    CrossrefPubMedGoogle Scholar
  • 15 Machalek DA, Poynten M, Jin F. , et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 2012; 13 (05) 487-500
    CrossrefPubMedGoogle Scholar
  • 16 Palefsky J. Human papillomavirus and anal neoplasia. Curr HIV/AIDS Rep 2008; 5 (02) 78-85
    CrossrefPubMedGoogle Scholar
  • 17 Darragh TM, Colgan TJ, Thomas Cox J. , et al; Members of the LAST Project Work Groups. The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gynecol Pathol 2013; 32 (01) 76-115
    CrossrefPubMedGoogle Scholar
  • 18 Solomon D, Davey D, Kurman R. , et al; Forum Group Members; Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287 (16) 2114-2119
    CrossrefPubMedGoogle Scholar
  • 19 Klingelhutz AJ, Foster SA, McDougall JK. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 1996; 380 (6569): 79-82
    CrossrefPubMedGoogle Scholar
  • 20 Fera D, Schultz DC, Hodawadekar S. , et al. Identification and characterization of small molecule antagonists of pRb inactivation by viral oncoproteins. Chem Biol 2012; 19 (04) 518-528
    CrossrefPubMedGoogle Scholar
  • 21 Thomas MK, Pitot HC, Liem A, Lambert PF. Dominant role of HPV16 E7 in anal carcinogenesis. Virology 2011; 421 (02) 114-118
    CrossrefPubMedGoogle Scholar
  • 22 de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004; 324 (01) 17-27
    CrossrefPubMedGoogle Scholar
  • 23 Assi R, Reddy V, Einarsdottir H, Longo WE. Anorectal human papillomavirus: current concepts. Yale J Biol Med 2014; 87 (04) 537-547
    PubMedGoogle Scholar
  • 24 Patel H, Wagner M, Singhal P, Kothari S. Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis 2013; 13: 39
    CrossrefPubMedGoogle Scholar
  • 25 Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007; 370 (9590): 890-907
    CrossrefPubMedGoogle Scholar
  • 26 Valmary-Degano S, Jacquin E, Prétet J-L. , et al. Signature patterns of human papillomavirus type 16 in invasive anal carcinoma. Hum Pathol 2013; 44 (06) 992-1002
    CrossrefPubMedGoogle Scholar
  • 27 De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franseschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009; 124 (07) 1626-1636
    CrossrefPubMedGoogle Scholar
  • 28 Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine 2006; 24 (Suppl. 03) S3 , 11–25
    CrossrefPubMedGoogle Scholar
  • 29 Tong WW, Hillman RJ, Kelleher AD, Grulich AE, Carr A. Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults. HIV Med 2014; 15 (02) 65-76
    CrossrefPubMedGoogle Scholar
  • 30 Lu B, Viscidi RP, Wu Y. , et al. Seroprevalence of human papillomavirus (HPV) type 6 and 16 vary by anatomic site of HPV infection in men. Cancer Epidemiol Biomarkers Prev 2012; 21 (09) 1542-1546
    CrossrefPubMedGoogle Scholar
  • 31 Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst 2009; 101 (16) 1120-1130
    CrossrefPubMedGoogle Scholar
  • 32 Cleary RK, Schaldenbrand JD, Fowler JJ, Schuler JM, Lampman RM. Perianal Bowen's disease and anal intraepithelial neoplasia: review of the literature. Dis Colon Rectum 1999; 42 (07) 945-951
    CrossrefPubMedGoogle Scholar
  • 33 Shiels MS, Cole SR, Kirk GD, Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr 2009; 52 (05) 611-622
    CrossrefPubMedGoogle Scholar
  • 34 Dunne EF, Unger ER, Sternberg M. , et al. Prevalence of HPV infection among females in the United States. JAMA 2007; 297 (08) 813-819
    CrossrefPubMedGoogle Scholar
  • 35 Satterwhite CL, Torrone E, Meites E. , et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis 2013; 40 (03) 187-193
    CrossrefPubMedGoogle Scholar
  • 36 Dandapani SV, Eaton M, Thomas Jr CR, Pagnini PG. HIV- positive anal cancer: an update for the clinician. J Gastrointest Oncol 2010; 1 (01) 34-44
    PubMedGoogle Scholar
  • 37 Stier EA, Sebring MC, Mendez AE, Ba FS, Trimble DD, Chiao EY. Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: a systematic review. Am J Obstet Gynecol 2015; 213 (03) 278-309
    CrossrefPubMedGoogle Scholar
  • 38 Schim van der Loeff MF, Mooij SH, Richel O, de Vries HJ, Prins JM. HPV and anal cancer in HIV-infected individuals: a review. Curr HIV/AIDS Rep 2014; 11 (03) 250-262
    CrossrefPubMedGoogle Scholar
  • 39 Piketty C, Darragh TM, Heard I. , et al. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis 2004; 31 (02) 96-99
    CrossrefPubMedGoogle Scholar
  • 40 Crum-Cianflone NF, Hullsiek KH, Marconi VC. , et al; Infectious Disease Clinical Research Program HIV Working Group. Anal cancers among HIV-infected persons: HAART is not slowing rising incidence. AIDS 2010; 24 (04) 535-543
    CrossrefPubMedGoogle Scholar
  • 41 Schwartz LM, Castle PE, Follansbee S. , et al. Risk factors for anal HPV infection and anal pre cancer in HIV-infected men who have sex with men. J Infect Dis (Auckl) 2013; 208: 768-775
    PubMedGoogle Scholar
  • 42 Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007; 370 (9581): 59-67
    CrossrefPubMedGoogle Scholar
  • 43 Tramujas da Costa e Silva I, de Lima Ferreira LC, Santos Gimenez F. , et al. High-resolution anoscopy in the diagnosis of anal cancer precursor lesions in renal graft recipients. Ann Surg Oncol 2008; 15 (05) 1470-1475
    CrossrefPubMedGoogle Scholar
  • 44 Jong E, van Gorp EC, Mulder JW, Tol A, Smits PH. Effect of HIV viral load, CD4 cell count and antiretroviral therapy on human papillomavirus prevalence in urine samples of HIV-infected men. Int J STD AIDS 2009; 20 (04) 262-264
    CrossrefPubMedGoogle Scholar
  • 45 Yu CT, Chao SC, Lee HC. , et al. High prevalence of anal human papillomavirus infection and associated risky behaviors in men infected with human immunodeficiency virus in Taiwan. AIDS Behav 2013; 17 (03) 1211-1218
    CrossrefPubMedGoogle Scholar
  • 46 Darwich L, Videla S, Cañadas MP. , et al; Can Ruti HIV-HPV Team. Distribution of human papillomavirus genotypes in anal cytological and histological specimens from HIV-infected men who have sex with men and men who have sex with women. Dis Colon Rectum 2013; 56 (09) 1043-1052
    CrossrefPubMedGoogle Scholar
  • 47 Piketty C, Darragh TM, Da Costa M. , et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med 2003; 138 (06) 453-459
    PubMedGoogle Scholar
  • 48 Donà MG, Benevolo M, Vocaturo A. , et al. Anal cytological abnormalities and epidemiological correlates among men who have sex with men at risk for HIV-1 infection. BMC Cancer 2012; 12: 476
    CrossrefPubMedGoogle Scholar
  • 49 Bedimo RJ, McGinnis KA, Dunlap M, Rodriguez-Barradas MC, Justice AC. Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression. J Acquir Immune Defic Syndr 2009; 52 (02) 203-208
    CrossrefPubMedGoogle Scholar
  • 50 Guiguet M, Boué F, Cadranel J, Lang JM, Rosenthal E, Costagliola D. ; Clinical Epidemiology Group of the FHDH-ANRS CO4 cohort. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol 2009; 10 (12) 1152-1159
    CrossrefPubMedGoogle Scholar
  • 51 Palefsky JM. Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women. J Natl Cancer Inst Monogr 1998; 1998 (23) 15-20
    CrossrefPubMedGoogle Scholar
  • 52 Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009; 124 (10) 2375-2383
    CrossrefPubMedGoogle Scholar
  • 53 Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 2011; 103 (05) 368-383
    CrossrefPubMedGoogle Scholar
  • 54 Mallari AO, Schwartz TM, Luque AE, Polashenski PS, Rauh SM, Corales RB. Anal cancer screening in HIV-infected patients: is it time to screen them all?. Dis Colon Rectum 2012; 55 (12) 1244-1250
    CrossrefPubMedGoogle Scholar
  • 55 Patel J, Salit IE, Berry MJ. , et al. Environmental scan of anal cancer screening practices: worldwide survey results. Cancer Med 2014; 3 (04) 1052-1061
    CrossrefPubMedGoogle Scholar
  • 56 Scholefield JH, Sonnex C, Talbot IC. , et al. Anal and cervical intraepithelial neoplasia: possible parallel. Lancet 1989; 2 (8666): 765-769
    PubMedGoogle Scholar
  • 57 Palefsky JM, Holly EA, Hogeboom CJ, Berry JM, Jay N, Darragh TM. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14 (05) 415-422
    CrossrefPubMedGoogle Scholar
  • 58 Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Palefsky JM. Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med 2000; 108 (08) 634-641
    CrossrefPubMedGoogle Scholar
  • 59 Fox PA, Seet JE, Stebbing J. , et al. The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinic. Sex Transm Infect 2005; 81 (02) 142-146
    CrossrefPubMedGoogle Scholar
  • 60 Arain S, Walts AE, Thomas P, Bose S. The anal Pap smear: cytomorphology of squamous intraepithelial lesions. Cytojournal 2005; 2 (01) 4
    CrossrefPubMedGoogle Scholar
  • 61 Cranston RD, Hart SD, Gornbein JA, Hirschowitz SL, Cortina G, Moe AA. The prevalence, and predictive value, of abnormal anal cytology to diagnose anal dysplasia in a population of HIV-positive men who have sex with men. Int J STD AIDS 2007; 18 (02) 77-80
    CrossrefPubMedGoogle Scholar
  • 62 Chin-Hong PV, Berry JM, Cheng SC. , et al. Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men. Ann Intern Med 2008; 149 (05) 300-306
    PubMedGoogle Scholar
  • 63 Salit IE, Lytwyn A, Raboud J. , et al. The role of cytology (Pap tests) and human papillomavirus testing in anal cancer screening. AIDS 2010; 24 (09) 1307-1313
    PubMedGoogle Scholar
  • 64 Nahas CS, da Silva Filho EV, Segurado AA. , et al. Screening anal dysplasia in HIV-infected patients: is there an agreement between anal pap smear and high-resolution anoscopy-guided biopsy?. Dis Colon Rectum 2009; 52 (11) 1854-1860
    CrossrefPubMedGoogle Scholar
  • 65 Sowah LA, Buchwald UK, Riedel DJ. , et al. Anal cancer screening in an urban HIV clinic: provider perceptions and practice. J Int Assoc Provid AIDS Care 2015; 14 (06) 497-504
    CrossrefPubMedGoogle Scholar
  • 66 Park IU, Palefsky JM. Evaluation and management of anal intraepithelial neoplasia in HIV-negative and HIV-positive men who have sex with men. Curr Infect Dis Rep 2010; 12 (02) 126-133
    CrossrefPubMedGoogle Scholar
  • 67 Katz KA, Clarke CA, Bernstein KT, Katz MH, Klausner JD. Is there a proven link between anal cancer screening and reduced morbidity or mortality?. Ann Intern Med 2009; 150 (04) 283-284 , author reply 284–285
    PubMedGoogle Scholar
  • 68 Richel O, Hallensleben ND, Kreuter A, van Noesel CJ, Prins JM, de Vries HJ. High-resolution anoscopy: clinical features of anal intraepithelial neoplasia in HIV-positive men. Dis Colon Rectum 2013; 56 (11) 1237-1242
    CrossrefPubMedGoogle Scholar
  • 69 Gimenez F, Costa-e-Silva IT, Daumas A, Araújo Jd, Medeiros SG, Ferreira L. The value of high-resolution anoscopy in the diagnosis of anal cancer precursor lesions in HIV-positive patients. Arq Gastroenterol 2011; 48 (02) 136-145
    CrossrefPubMedGoogle Scholar
  • 70 Heráclio SA, Schettini J, Oliveira ML, Souza AS, Souza PR, Amorim MM. High-resolution anoscopy in women with cervical neoplasia. Int J Gynaecol Obstet 2015; 128 (03) 216-219
    CrossrefPubMedGoogle Scholar
  • 71 Sendagorta E, Herranz P, Guadalajara H. , et al. Prevalence of abnormal anal cytology and high-grade squamous intraepithelial lesions among a cohort of HIV-infected men who have sex with men. Dis Colon Rectum 2014; 57 (04) 475-481
    CrossrefPubMedGoogle Scholar
  • 72 Richel O, Prins JM, de Vries HJ. Screening for anal cancer precursors: what is the learning curve for high-resolution anoscopy?. AIDS 2014; 28 (09) 1376-1377
    CrossrefPubMedGoogle Scholar
  • 73 Berry JM, Palefsky JM, Jay N, Cheng SC, Darragh TM, Chin-Hong PV. Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia. Dis Colon Rectum 2009; 52 (02) 239-247
    CrossrefPubMedGoogle Scholar
  • 74 Macaya A, Muñoz-Santos C, Balaguer A, Barberà MJ. Interventions for anal canal intraepithelial neoplasia. Cochrane Database Syst Rev 2012; 12: CD009244
    PubMedGoogle Scholar
  • 75 Long KC, Menon R, Bastawrous A, Billingham R. Screening, surveillance, and treatment of anal intraepithelial neoplasia. Clin Colon Rectal Surg 2016; 29 (01) 57-64
    Article in Thieme ConnectPubMedGoogle Scholar
  • 76 Crawshaw BP, Russ AJ, Stein SL. , et al. High-resolution anoscopy or expectant management for anal intraepithelial neoplasia for the prevention of anal cancer: is there really a difference?. Dis Colon Rectum 2015; 58 (01) 53-59
    CrossrefPubMedGoogle Scholar
  • 77 Dillner J, Kjaer SK, Wheeler CM. , et al; FUTURE I/II Study Group. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ 2010; 341: c3493
    CrossrefPubMedGoogle Scholar
  • 78 Wangu Z, Hsu KK. Impact of HPV vaccination on anogenital warts and respiratory papillomatosis. Hum Vaccin Immunother 2016; 12 (06) 1357-1362
    CrossrefPubMedGoogle Scholar
  • 79 Swedish KA, Factor SH, Goldstone SE. Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study. Clin Infect Dis 2012; 54 (07) 891-898
    CrossrefPubMedGoogle Scholar
  • 80 Palefsky JM, Giuliano AR, Goldstone S. , et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011; 365 (17) 1576-1585
    CrossrefPubMedGoogle Scholar
  • 81 Centers for Disease Control and Prevention (CDC). Recommendations on the use of quadrivalent human papillomavirus vaccine in males—Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011; 60 (50) 1705-1708
    PubMedGoogle Scholar
  • 82 Deshmukh AA, Chiao EY, Das P, Cantor SB. Clinical effectiveness and cost-effectiveness of quadrivalent human papillomavirus vaccination in HIV-negative men who have sex with men to prevent recurrent high-grade anal intraepithelial neoplasia. Vaccine 2014; 32 (51) 6941-6947
    CrossrefPubMedGoogle Scholar
  • 83 Machalek DA, Grulich AE, Hillman RJ. , et al; SPANC Study Team. The Study of the Prevention of Anal Cancer (SPANC): design and methods of a three-year prospective cohort study. BMC Public Health 2013; 13: 946
    CrossrefPubMedGoogle Scholar
  • 84 The ANCHOR Study. Available at: https://anchorstudy.org . Accessed February 9, 2018
    PubMed
  • 85 Jemal A, Simard EP, Dorell C. , et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 2013; 105 (03) 175-201
    CrossrefPubMedGoogle Scholar